Lyell Immunopharma, Inc. reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
South San Francisco, CA
SEC filing record 1 source field available
Fiscal year end
31 December
Lyell Immunopharma, Inc. has filed 349 SEC EDGAR filings since 20 Mar 2020

SEC filing history

Showing 1-25 of 349 matching filings.

Per page
25
Current page
1
4

4 filing

Filing date
25 Aug 2026
Reporting date
21 Aug 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
25 Aug 2026
Reporting date
21 Aug 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
25 Aug 2026
Reporting date
21 Aug 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
SCHEDULE 13G/A File 005-93402

SCHEDULE 13G/A filing

Filing date
14 Aug 2026
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
11 Aug 2026
Reporting date
10 Aug 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
11 Aug 2026
Reporting date
10 Aug 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
11 Aug 2026
Reporting date
10 Aug 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
11 Aug 2026
Reporting date
10 Aug 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
27 Jul 2026
Reporting date
27 Jul 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
27 Jul 2026
Reporting date
27 Jul 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
EFFECT File 333-297433

EFFECT filing

Filing date
21 Jul 2026
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
20 Jul 2026
Reporting date
17 Jul 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
17 Jul 2026
Reporting date
16 Jul 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
CORRESP

CORRESP filing

Filing date
17 Jul 2026
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
UPLOAD File 333-297433

UPLOAD filing

Filing date
16 Jul 2026
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
01 Jul 2026
Reporting date
29 Jun 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
18 Jun 2026
Reporting date
15 Jun 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
SCHEDULE 13G/A File 005-93402

SCHEDULE 13G/A filing

Filing date
18 Jun 2026
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
3

FORM 3

Filing date
18 Jun 2026
Reporting date
18 May 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
15 Jun 2026
Reporting date
11 May 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
15 Jun 2026
Reporting date
11 May 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
15 Jun 2026
Reporting date
11 May 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .